Aggregate Data Review for Signal Identification in Clinical Trials
Aggregate data review involves evaluating cumulative safety information collected from all subjects in a clinical trial—or across multiple trials involving the same investigational product. This includes a consolidated analysis of adverse events (AEs), serious adverse events (SAEs), lab values, vital signs, and other clinical outcomes to detect potential safety signals.
Click to read the full article.
